Head-to-head comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in staging prostate cancer using histopathology and immunohistochemical analysis as a reference standard J Kuten, I Fahoum, Z Savin, O Shamni, G Gitstein, D Hershkovitz, ... Journal of Nuclear Medicine 61 (4), 527-532, 2020 | 170 | 2020 |
Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma J Kuten, C Levine, O Shamni, S Pelles, I Wolf, G Lahat, E Mishani, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-8, 2022 | 75 | 2022 |
[68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up? J Kuten, D Sarid, O Yossepowitch, NJ Mabjeesh, E Even-Sapir EJNMMI research 9, 1-8, 2019 | 23 | 2019 |
Brain metastasis of nasopharyngeal carcinoma: a case report and literature review O Kaidar-Person, J Kuten, F Atrash, S Billan, A Kuten Case Reports in Medicine 2012, 2012 | 23 | 2012 |
The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0 J Kuten, S Dekalo, I Mintz, O Yossepowitch, R Mano, E Even-Sapir EJNMMI research 11, 1-8, 2021 | 21 | 2021 |
Personalized radiation dosimetry for PRRT—how many scans are really required? N Freedman, M Sandström, J Kuten, N Shtraus, I Ospovat, A Schlocker, ... EJNMMI physics 7, 1-15, 2020 | 21 | 2020 |
68Ga-PSMA PET/CT: does it predict adverse pathology findings at radical prostatectomy? S Dekalo, J Kuten, NJ Mabjeesh, A Beri, E Even-Sapir, O Yossepowitch Urologic Oncology: Seminars and Original Investigations 37 (9), 574. e19-574 …, 2019 | 20 | 2019 |
Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate-and High-Risk Prostate Cancer. J Kuten, NJ Mabjeesh, H Lerman, C Levine, S Barnes, E Even-Sapir The Israel Medical Association journal: IMAJ 21 (2), 100-104, 2019 | 19 | 2019 |
[18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: proof-of-concept study J Kuten, A Linevitz, H Lerman, N Freedman, M Kestenbaum, T Shiner, ... Journal of Integrative Neuroscience 19 (3), 489-494, 2020 | 12 | 2020 |
Preoperative 68Ga-PSMA PET/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissection S Dekalo, J Kuten, I Mintz, I Fahoum, G Gitstein, D Keizman, D Sarid, ... Prostate Cancer and Prostatic Diseases 24 (3), 910-916, 2021 | 10 | 2021 |
Anaplastic ganglioglioma in the spinal cord: case report and literature review J Kuten, O Kaidar-Person, E Vlodavsky, S Postovsky, S Billan, A Kuten, ... Pediatric Neurosurgery 48 (4), 245-248, 2013 | 10 | 2013 |
Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement M Kesler, K Kerzhner, I Druckmann, J Kuten, C Levine, D Sarid, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-9, 2022 | 9 | 2022 |
Long-term scopolamine treatment and dental caries E Galili, E Averbuch Zehavi, Y Zadik, T Caspi, L Meltzer, I Merdler, J Kuten, ... Clinical Oral Investigations 23, 2339-2344, 2019 | 7 | 2019 |
68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for patients with favorable intermediate-risk prostate cancer S Dekalo, J Kuten, J Campbell, I Mintz, Y Bar-Yosef, D Keizman, D Sarid, ... Canadian Urological Association Journal 16 (7), E381, 2022 | 5 | 2022 |
1: CAS: 528: DC% 2BB3cXhvVOisbjK: Head-to-head comparison of (68) Ga-PSMA-11 with (18) F-PSMA-1007 PET/CT in staging prostate cancer using histopathology and … J Kuten, I Fahoum, Z Savin, O Shamni, G Gitstein, D Hershkovitz J Nucl Med, 527-532, 2020 | 5 | 2020 |
The added value of 18F-FDOPA PET/CT in the work-up of patients with movement disorders K Khamis, N Giladi, C Levine, M Kesler, J Kuten, H Lerman, E Even-Sapir Neurographics 9 (5), 344-348, 2019 | 4 | 2019 |
The role of PSMA PET/CT in imaging prostate cancer J Kuten, M Kesler, E Even-Sapir Harefuah 160 (7), 455-461, 2021 | 3 | 2021 |
68Ga-PSMA-11 PET/CT follow-up of patients with prostate cancer with bone metastases who had reduced bone density after androgen deprivation therapy M Kesler, I Druckmann, C Levine, J Kuten, O Yossepowitch, E Even-Sapir Diagnostics 11 (2), 277, 2021 | 3 | 2021 |
Gastrointestinal stromal tumor of the ampulla of Vater. E Brauner, J Kuten, O Ben-Ishay, D Hershkovitz, Y Kluger The Israel Medical Association journal: IMAJ 14 (9), 588-589, 2012 | 3 | 2012 |
Kansallinen omakuva ja kielteiset tunteet R Rossi, E Nykänen | 2 | 2020 |